On Saturday, the patent for the AIDS drug AZT expired. Manufacturer GlaxoSmithKline now faces competition from generics and pressure from stockholders. Host Connie Walker speaks with Leo John, biotech reporter with the Triangle Business Journal, about how the expiration of the patent will effect GlaxoSmithKline and how AZT fits in to modern AIDS drug markets. (12:00)